Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47K Buy
+227
New +$5.94K ﹤0.01% 1076
2024
Q4
Sell
-16,462
Closed -$476K 1919
2024
Q3
$476K Buy
16,462
+15,363
+1,398% +$448K 0.12% 165
2024
Q2
$30.8K Buy
+1,099
New +$30.3K 0.01% 898

Other funds holding PFE

Quarry LP's PFE Position: Q2 2026 in Review

Quarry LP opened a new position in Pfizer (PFE) in Q2 2026: 227 shares worth $5.47K. The stake represents ﹤0.01% of the portfolio and ranks #1076 among its holdings. This is a return to the name: Quarry LP previously reported a position in PFE as recently as Q3 2024.

Quarry LP first reported a position in PFE in Q2 2024 and has held it in 3 quarters since. The position peaked at $476K in Q3 2024. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Quarry LP held 227 shares of Pfizer worth $5.47K as of Q2 2026.
  • Pfizer was a new Quarry LP position in Q2 2026.
  • Pfizer made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1076 holding.
  • Quarry LP first reported a position in Pfizer in Q2 2024 and has held it in 3 quarters since.
  • Quarry LP's Pfizer position peaked at $476K in Q3 2024.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.